EUVIMEDEUVIMED entdecken
Open Access

One-Year Outcomes Among Children Identified With Celiac Disease Through a Mass Screening Program

Marisa G Stahl, Zhaoxing Pan, Monique Germone, Sadie Nagle, Pooja Mehta, Mary Shull, Isabel Griffith, Brianne Shuler, Edward Hoffenberg, Iman Taki, Cristy Geno-Rasmussen, Marian J Rewers und 3 weitere

Clinical Gastroenterology and Hepatology · 2025

DOI: 10.1016/j.cgh.2024.03.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025. Verfasst von Marisa G Stahl und 14 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Health Institute, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electroni…. Hauptthemen laut MEDLINE: Celiac Disease, Mass Screening. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Beyond Celiac, Leona M and Harry B Helmsley Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Celiac disease (CD) mass screening remains controversial in part because of a paucity of data to support its benefit. The Autoimmunity Screening for Kids study is a mass screening study for pediatric CD and type 1 diabetes in Colorado. METHODS: This study prospectively follows up children ages 1 to 17 years who screened positive for tissue transglutaminase IgA autoantibodies in the Autoimmunity Screening for Kids study subsequently referred for diagnostic evaluation. Children diagnosed with CD by biopsy or serologic criteria were included in this study. Evaluation at baseline and 12 month follow-up evaluation included demographics, laboratory studies, symptoms, health-related quality of life, anxiety/depression, and gluten-free diet adherence. Paired Student t test, chi-square, and Wilcoxon signed-rank tests compared baseline and follow-up data. For symptom scores, odds of improvement were assessed. RESULTS: Of the 52 children with CD enrolled, 42 children completed 12-month follow-up evaluation. On the symptom questionnaire completed at diagnostic evaluation, 38 of 42 children reported 1 or more symptoms. CD mean symptom severity and frequency scores improved from baseline to follow-up evaluation (P < .001). Reported health-related quality of life scores improved among caregivers (P = .002). There was no significant change in reported anxiety or depression. Iron deficiency without anemia was common at baseline (21 of 24 children; 87.5%) and normalized at follow-up evaluation (11 of 21 children; 52.3%). Twenty-six of 28 families reported good or excellent gluten-free diet adherence. CONCLUSIONS: This novel study of children with CD identified through a mass screening program demonstrated improvement in symptoms, quality of life, and iron deficiency after 1 year follow-up evaluation. This demonstrates that there may be benefit to CD mass screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseMass ScreeningHumansMaleFemaleChildAdolescentChild, PreschoolInfantProspective StudiesColoradoQuality of LifeAutoantibodiesFollow-Up StudiesImmunoglobulin ATransglutaminasesSurveys and QuestionnairesGTP-Binding ProteinsDiet, Gluten-FreeProtein Glutamine gamma Glutamyltransferase 2

Stichwörter der Autor:innen

Celiac DiseaseOutcomesScreening

Substanzen

AutoantibodiesImmunoglobulin ATransglutaminasesGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2

Autor:innen und Institutionen

  • Digestive Health Institute, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address: marisa.stahl@childrenscolorado.org.
  • Child Health Research Biostatistics Core, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Digestive Health Institute, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Barbara Davis Center for Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Förderung

  • NIDDK NIH HHS
  • Beyond Celiac
  • Leona M and Harry B Helmsley Charitable Trust
  • Juvenile Diabetes Research Foundation Canada
  • JDRF

Zitieren

APA

Stahl, M. G., Pan, Z., Germone, M., Nagle, S., Mehta, P., Shull, M., Griffith, I., Shuler, B., Hoffenberg, E., Taki, I., Geno-Rasmussen, C., Rewers, M. J., Norris, J. M., Liu, E., & ASK Study Group (2025). One-Year Outcomes Among Children Identified With Celiac Disease Through a Mass Screening Program. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.03.030

Vancouver

Stahl MG, Pan Z, Germone M, Nagle S, Mehta P, Shull M, et al. One-Year Outcomes Among Children Identified With Celiac Disease Through a Mass Screening Program. Clinical Gastroenterology and Hepatology. 2025. doi:10.1016/j.cgh.2024.03.030

BibTeX
@article{Stahl2025,
  author = {Stahl, Marisa G and Pan, Zhaoxing and Germone, Monique and Nagle, Sadie and Mehta, Pooja and Shull, Mary and Griffith, Isabel and Shuler, Brianne and Hoffenberg, Edward and Taki, Iman and Geno-Rasmussen, Cristy and Rewers, Marian J and Norris, Jill M and Liu, Edwin and ASK Study Group, ASK Study Group},
  title = {One-Year Outcomes Among Children Identified With Celiac Disease Through a Mass Screening Program},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1016/j.cgh.2024.03.030}
}
Kostenlos starten →